Syntellix AG acquires 100 percent of shares in MSE
Syntellix has acquired 100 percent of the shares in MSE Materials Science and Engineering Werkstoffzentrum Clausthal GmbH. The relevant contracts were signed and notarised last week in Hannover. It was only in August 2018 that biomedical technology innovator Syntellix announced the acquisition of a 73% majority stake in materials specialist MSE. The complete takeover of its long-standing production and research partner will enable Syntellix to make its processes even more efficient, to exercise greater direct control of machine capacity and production activity, to integrate its substantial expertise even more closely in the company and thus expand its technology leadership.
The globally renowned magnesium experts and former MSE owners Prof. Dr.-Ing. Volkmar Neubert and his son Volkmar-Dirk Neubert will remain with the Syntellix Group and the MSE team in their roles as CEOs.
“With the complete takeover of MSE, we were able to strategically strengthen our unique position in bioabsorbable metallic implants for orthopaedics and trauma surgery, and with regard to the planned IPO to also adequately substantiate MSE’s importance in the past and future development of innovative implants made from our MAGNEZIX®,” says CEO Prof. Dr. Utz Claassen.